{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:43:37Z","timestamp":1790311417774,"version":"4.1.0"},"reference-count":83,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T00:00:00Z","timestamp":1645920000000},"content-version":"unspecified","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,1,27]]},"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To prioritise vaccines for introduction in Bangladesh.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Multicriteria decision analysis (MCDA) process was used to prioritise potential vaccines for introduction in Bangladesh. A set of criteria were identified, weighted and assigned scores by relevant stakeholders (n=14) during workshop A. The performance matrix of the data of vaccines against the criteria set was constructed and validated with the experts (n=6) in workshop B. The vaccines were ranked and appraised by another group of stakeholders (n=10) in workshop C, and the final workshop D involved the dissemination of the findings to decision-makers (n=28).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five criteria including incidence rate, case fatality rate, vaccine efficacy, size of the population at risk and type of population at risk were used quantitatively to evaluate and to score the vaccines. Two other criteria, cost-effectiveness and outbreak potentiality, were considered qualitatively. On deliberation, the Japanese encephalitis (JE) vaccine was ranked top to be recommended for introduction in Bangladesh.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Based on the MCDA results, JE vaccine is planned to be recommended to the decision-makers for introduction into the national vaccine benefit package. The policymakers support the use of systematic evidence-based decision-making processes such as MCDA for vaccine introduction in Bangladesh, and to prioritise health interventions in the country.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-054219","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T11:02:18Z","timestamp":1646046138000},"page":"e054219","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Priority setting of vaccine introduction in Bangladesh: a multicriteria decision analysis study"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0013-0051","authenticated-orcid":false,"given":"Mohammad Sabbir","family":"Haider","sequence":"first","affiliation":[{"name":"Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, Thailand"},{"name":"Directorate General of Health Services, Government of Bangladesh Ministry of Health and Family Welfare, Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2448-3954","authenticated-orcid":false,"given":"Sitaporn","family":"Youngkong","sequence":"additional","affiliation":[{"name":"Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, Thailand"},{"name":"Social and Administrative Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8256-2167","authenticated-orcid":false,"given":"Montarat","family":"Thavorncharoensap","sequence":"additional","affiliation":[{"name":"Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, Thailand"},{"name":"Social and Administrative Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4122-2366","authenticated-orcid":false,"given":"Praveen","family":"Thokala","sequence":"additional","affiliation":[{"name":"Health Economics and Decision Science, School of Health and Related Research (ScHARR), The University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,2,28]]},"reference":[{"key":"2025121600182792000_12.2.e054219.1","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/14760584.2017.1382358","article-title":"Improving accountability in vaccine decision-making","volume":"16","author":"Timmis","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"2025121600182792000_12.2.e054219.2","unstructured":"Brenzel L , Wolfson LJ , Fox-Rushby J . Vaccine-Preventable Diseases\u2014Chapter 20. Disease Control Priorities in Developing Countries:389\u2013411."},{"key":"2025121600182792000_12.2.e054219.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00377-3"},{"key":"2025121600182792000_12.2.e054219.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00623-0"},{"key":"2025121600182792000_12.2.e054219.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2018.08.005"},{"key":"2025121600182792000_12.2.e054219.6","doi-asserted-by":"crossref","first-page":"615","DOI":"10.15171\/ijhpm.2016.83","article-title":"Priority setting for universal health coverage: we need evidence-informed Deliberative processes, not just more evidence on cost-effectiveness","volume":"5","author":"Baltussen","year":"2016","journal-title":"Int J Health Policy Manag"},{"key":"2025121600182792000_12.2.e054219.7","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-016-0624-4","article-title":"Ethical priority setting for universal health coverage: challenges in deciding upon fair distribution of health services","volume":"14","author":"Norheim","year":"2016","journal-title":"BMC Med"},{"key":"2025121600182792000_12.2.e054219.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2009.02311.x"},{"key":"2025121600182792000_12.2.e054219.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2007.05.054"},{"key":"2025121600182792000_12.2.e054219.10","doi-asserted-by":"publisher","DOI":"10.1186\/1478-7547-4-14"},{"key":"2025121600182792000_12.2.e054219.11","doi-asserted-by":"publisher","DOI":"10.1186\/1478-7547-2-3"},{"key":"2025121600182792000_12.2.e054219.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.06.015"},{"key":"2025121600182792000_12.2.e054219.13","doi-asserted-by":"crossref","unstructured":"Marsh K , Goetghebeur M , Thokala P . Multi-Criteria decision analysis to support healthcare decisions. Springer, 2017.","DOI":"10.1007\/978-3-319-47540-0"},{"key":"2025121600182792000_12.2.e054219.14","doi-asserted-by":"crossref","unstructured":"Haque F , Hossain MJ , Kundu SK . Cholera Outbreaks in Urban Bangladesh. In: Sunnyvale, ed. 2011. Epidemiology. 3, 2013.","DOI":"10.4172\/2161-1165.1000126"},{"key":"2025121600182792000_12.2.e054219.15","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2010.09-0125"},{"key":"2025121600182792000_12.2.e054219.16","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2011.10-0706"},{"key":"2025121600182792000_12.2.e054219.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.06.001"},{"key":"2025121600182792000_12.2.e054219.18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005475","article-title":"Dengue seroprevalence, seroconversion and risk factors in Dhaka, Bangladesh","volume":"11","author":"Dhar-Chowdhury","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"2025121600182792000_12.2.e054219.19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3329\/jhpn.v31i2.16385","article-title":"Introduction of new vaccines: decision-making process in Bangladesh","volume":"31","author":"Uddin","year":"2013","journal-title":"J Health Popul Nutr"},{"key":"2025121600182792000_12.2.e054219.20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jval.2015.12.016","article-title":"Multiple Criteria Decision Analysis for Health Care Decision Making--Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force","volume":"19","author":"Marsh","year":"2016","journal-title":"Value Health"},{"key":"2025121600182792000_12.2.e054219.21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jval.2015.12.003","article-title":"Multiple Criteria Decision Analysis for Health Care Decision Making--An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force","volume":"19","author":"Thokala","year":"2016","journal-title":"Value Health"},{"key":"2025121600182792000_12.2.e054219.22","unstructured":"Haider MS . Multi-Criteria Decision Analysis for Priority Setting of Vaccine Introduction in Bangladesh [Ph.D. Thesis] 2020:Mahidol University."},{"key":"2025121600182792000_12.2.e054219.23","unstructured":"Roszkowska E . Rank ordering criteria weighting methods\u2013a comparative overview; 2013."},{"key":"2025121600182792000_12.2.e054219.24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.proeng.2015.10.019","article-title":"Influence of data transformation on multicriteria evaluation result","volume":"122","author":"Podviezko","year":"2015","journal-title":"Procedia Engineering"},{"key":"2025121600182792000_12.2.e054219.25","unstructured":"Normalization techniques for multi-criteria decision making: analytical hierarchy process case study. 2016, Springer"},{"key":"2025121600182792000_12.2.e054219.26","doi-asserted-by":"crossref","unstructured":"Marsh K , Thokala P , M\u00fchlbacher A . Incorporating Preferences and Priorities into MCDA: Selecting an Appropriate Scoring and Weighting Technique. In: Marsh K , Goetghebeur M , Thokala P , eds. Multi-Criteria decision analysis to support healthcare decisions. Cham: Springer International Publishing, 2017: 47\u201366.","DOI":"10.1007\/978-3-319-47540-0_4"},{"key":"2025121600182792000_12.2.e054219.27","unstructured":"World Health Organization . WHO recommendations for routine immunization - summary tables 2019 [updated 26 April 2019; cited 2019 21 November 2019], 2019. Available: https:\/\/www.who.int\/immunization\/policy\/immunization_tables\/en\/ [Accessed 21 November, 2019]."},{"key":"2025121600182792000_12.2.e054219.28","unstructured":"Gavi The Vaccine Alliance . Gavi, The Vaccine Alliance-Vaccine Support 2019 [cited 2019 21 November 2019]. Available: https:\/\/www.gavi.org\/programmes-impact\/types-support\/vaccine-support"},{"key":"2025121600182792000_12.2.e054219.29","unstructured":"Centers for Disease Control and Prevention . Centers for disease control and prevention 2019, 2019. Available: https:\/\/www.cdc.gov\/vaccines\/ [Accessed 21 November 2019]."},{"key":"2025121600182792000_12.2.e054219.30","unstructured":"Rashid K . Hyder\u2019s Textbook of community Medicine and public Health. Dhaka RHM publishers; 2008."},{"key":"2025121600182792000_12.2.e054219.31","unstructured":"World Health Organization . World Health Statistics 2012 - Indicator compendium: World Health Organization; 2012."},{"key":"2025121600182792000_12.2.e054219.32","unstructured":"World Health Organization . Global reference list of 100 core health indicators: World Health organization; 2015."},{"key":"2025121600182792000_12.2.e054219.33","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7272.1300"},{"key":"2025121600182792000_12.2.e054219.34","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1016\/j.vaccine.2014.09.009","article-title":"Prioritization of the introduction of new vaccines to the National immunization program in the Republic of Korea","volume":"32","author":"Choe","year":"2014","journal-title":"Vaccine"},{"key":"2025121600182792000_12.2.e054219.35","doi-asserted-by":"crossref","first-page":"A39","DOI":"10.1016\/j.vaccine.2010.02.031","article-title":"The National Committee for vaccines regulation and surveillance of vaccine-preventable diseases in the Sultanate of Oman: evidence-based approach and consensus decision-making","volume":"28 Suppl 1","author":"Al Awaidy","year":"2010","journal-title":"Vaccine"},{"key":"2025121600182792000_12.2.e054219.36","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czw038"},{"key":"2025121600182792000_12.2.e054219.37","doi-asserted-by":"crossref","DOI":"10.1016\/j.healthpol.2018.09.001","article-title":"Evidence-Informed vaccine decision making: the introduction of human papilloma virus (HPV) vaccination in the Netherlands","volume":"123","author":"van der Putten","year":"2019","journal-title":"Health Policy"},{"key":"2025121600182792000_12.2.e054219.38","first-page":"ii62","article-title":"National decision-making on adopting new vaccines: a systematic review","volume":"27 Suppl 2","author":"Burchett","year":"2012","journal-title":"Health Policy Plan"},{"key":"2025121600182792000_12.2.e054219.39","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czw038"},{"key":"2025121600182792000_12.2.e054219.40","first-page":"945","article-title":"NTAGI Subcommittee recommendations on Haemophilus influenzae type B (Hib) vaccine introduction in India","volume":"46","author":"Kant","year":"2009","journal-title":"Indian Pediatr"},{"key":"2025121600182792000_12.2.e054219.41","first-page":"ii39","article-title":"New vaccine adoption in lower-middle-income countries","volume":"27 Suppl 2","author":"Makinen","year":"2012","journal-title":"Health Policy Plan"},{"key":"2025121600182792000_12.2.e054219.42","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-015-1638-0"},{"key":"2025121600182792000_12.2.e054219.43","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.vaccine.2018.11.062","article-title":"Developing a seasonal influenza vaccine recommendation in Kenya: process and challenges faced by the National immunization technical Advisory group (NITAG)","volume":"37","author":"Dawa","year":"2019","journal-title":"Vaccine"},{"key":"2025121600182792000_12.2.e054219.44","first-page":"945","article-title":"NTAGI Subcommittee recommendations on Haemophilus influenzae type B (Hib) vaccine introduction in India","volume":"46","author":"","year":"2009","journal-title":"Indian Pediatr"},{"key":"2025121600182792000_12.2.e054219.45","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-016-3382-5","article-title":"What criteria do decision makers in Thailand use to set priorities for vaccine introduction?","volume":"16","author":"Pooripussarakul","year":"2016","journal-title":"BMC Public Health"},{"key":"2025121600182792000_12.2.e054219.46","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jval.2019.06.014","article-title":"Multicriteria decision analysis to support health technology assessment agencies: benefits, limitations, and the way forward","volume":"22","author":"Baltussen","year":"2019","journal-title":"Value Health"},{"key":"2025121600182792000_12.2.e054219.47","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jval.2021.04.1273","article-title":"The CAPACITI Decision-Support tool for national immunization programs","volume":"24","author":"Botwright","year":"2021","journal-title":"Value Health"},{"key":"2025121600182792000_12.2.e054219.48","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1016\/j.vaccine.2015.05.078","article-title":"Introduction of a national HPV vaccination program into Bhutan","volume":"33","author":"Dorji","year":"2015","journal-title":"Vaccine"},{"key":"2025121600182792000_12.2.e054219.49","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1007\/s00431-002-1065-y","article-title":"Time to recommend pneumococcal vaccination for all children in Europe: experience in France","volume":"161 Suppl 2","author":"Fletcher","year":"2002","journal-title":"Eur J Pediatr"},{"key":"2025121600182792000_12.2.e054219.50","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/14034948010290041201","article-title":"Immunization against Haemophilus influenzae type b in Sweden--a study of the introduction process","volume":"29","author":"Garpenholt","year":"2001","journal-title":"Scand J Public Health"},{"key":"2025121600182792000_12.2.e054219.51","doi-asserted-by":"crossref","first-page":"C9","DOI":"10.1016\/j.vaccine.2012.04.027","article-title":"The decision making process on new vaccines introduction in South Africa","volume":"30 Suppl 3","author":"Ngcobo","year":"2012","journal-title":"Vaccine"},{"key":"2025121600182792000_12.2.e054219.52","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jval.2017.10.001","article-title":"The use of MCDA in HTa: great potential, but more effort needed","volume":"21","author":"Marsh","year":"2018","journal-title":"Value Health"},{"key":"2025121600182792000_12.2.e054219.53","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12962-018-0125-8","article-title":"Incorporating MCDA into HTa: challenges and potential solutions, with a focus on lower income settings","volume":"16","author":"Marsh","year":"2018","journal-title":"Cost Eff Resour Alloc"},{"key":"2025121600182792000_12.2.e054219.54","doi-asserted-by":"publisher","DOI":"10.1002\/hec.1380"},{"key":"2025121600182792000_12.2.e054219.55","unstructured":"Airoldi M , Morton A , Smith J . Healthcare prioritisation at the local level: a socio-technical approach 2011."},{"key":"2025121600182792000_12.2.e054219.56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006652","article-title":"The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: a disease modeling and economic analysis","volume":"12","author":"Khan","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"2025121600182792000_12.2.e054219.57","first-page":"517","article-title":"Cholera, 2014","volume":"90","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"2025121600182792000_12.2.e054219.58","unstructured":"Hossain MA , AHMM L , Rayhan MI . Population projection of Bangladesh: dynamics and trends 2011-2061. Dhaka, Bangladesh: Bangladesh Bureay of Statistics, Statistics and Information Division, Ministry of Planning, 2015."},{"key":"2025121600182792000_12.2.e054219.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtbi.2012.12.021"},{"key":"2025121600182792000_12.2.e054219.60","unstructured":"Haider S , Chaikledkaew U , Thavorncharoensap M . Cost-Effectiveness of dengue vaccine introduction in Dhaka City, Bangladesh. HTAsiaLink. Thailand: Chiang Mai, 2018."},{"key":"2025121600182792000_12.2.e054219.61","first-page":"349","article-title":"Dengue vaccine: who position paper \u2013 July 2016","volume":"91","year":"2016","journal-title":"Wkly Epidemiol Rec"},{"key":"2025121600182792000_12.2.e054219.62","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.vaccine.2016.10.070","article-title":"Dengue vaccine: WHO position paper, July 2016 - recommendations","volume":"35","year":"2017","journal-title":"Vaccine"},{"key":"2025121600182792000_12.2.e054219.63","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.vaccine.2019.10.037","article-title":"Cost-Effectiveness of the introduction of two-dose bi-valent (Cervarix) and quadrivalent (Gardasil) HPV vaccination for adolescent girls in Bangladesh","volume":"38","author":"Mahumud","year":"2020","journal-title":"Vaccine"},{"key":"2025121600182792000_12.2.e054219.64","unstructured":"Services DGoH . National strategy for cervical cancer prevention and control Bangladesh (2017-2022): Directorate General of health services; 2017."},{"key":"2025121600182792000_12.2.e054219.65","doi-asserted-by":"crossref","first-page":"e406","DOI":"10.1016\/S2214-109X(14)70237-2","article-title":"Cost-Effectiveness of female human papillomavirus vaccination in 179 countries: a prime modelling study","volume":"2","author":"Jit","year":"2014","journal-title":"Lancet Glob Health"},{"key":"2025121600182792000_12.2.e054219.66","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.1016\/j.vaccine.2017.10.103","article-title":"Modeling the consequences of regional heterogeneity in human papillomavirus (HPV) vaccination uptake on transmission in Switzerland","volume":"35","author":"Riesen","year":"2017","journal-title":"Vaccine"},{"key":"2025121600182792000_12.2.e054219.67","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/irv.12490","article-title":"Estimates of seasonal influenza-associated mortality in Bangladesh, 2010-2012","volume":"12","author":"Ahmed","year":"2018","journal-title":"Influenza Other Respir Viruses"},{"key":"2025121600182792000_12.2.e054219.68","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181bc23fd"},{"key":"2025121600182792000_12.2.e054219.69","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0708630"},{"key":"2025121600182792000_12.2.e054219.70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171499","article-title":"Cost-Effectiveness of maternal influenza immunization in Bamako, Mali: a decision analysis","volume":"12","author":"Orenstein","year":"2017","journal-title":"PLoS One"},{"key":"2025121600182792000_12.2.e054219.71","first-page":"288","article-title":"Reproduction numbers of infectious disease models","volume":"2","author":"van den Driessche","year":"2017","journal-title":"Infect Dis Model"},{"key":"2025121600182792000_12.2.e054219.72","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1016\/j.vaccine.2010.04.086","article-title":"A cost-effectiveness analysis of Japanese encephalitis vaccine in Cambodia","volume":"28","author":"Touch","year":"2010","journal-title":"Vaccine"},{"key":"2025121600182792000_12.2.e054219.73","first-page":"69","article-title":"Japanese encephalitis vaccines: who position paper","volume":"90","year":"2015","journal-title":"Weekly Epidemiological Record= Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire"},{"key":"2025121600182792000_12.2.e054219.74","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.04.052"},{"key":"2025121600182792000_12.2.e054219.75","unstructured":". Estimation of parameters and basic reproductive ratio for Japanese encephalitis transmission in the Philippines using a sequential Monte Carlo filter. 2017 IEEE Conference on Control Technology and Applications (CCTA). IEEE, 2017."},{"key":"2025121600182792000_12.2.e054219.76","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/21645515.2017.1356962","article-title":"Cost-Effectiveness analysis of introducing universal childhood rotavirus vaccination in Bangladesh","volume":"14","author":"Sarker","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"2025121600182792000_12.2.e054219.77","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1001\/jamapediatrics.2018.1960","article-title":"Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years","volume":"172","author":"Troeger","year":"2018","journal-title":"JAMA Pediatr"},{"key":"2025121600182792000_12.2.e054219.78","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60755-6"},{"key":"2025121600182792000_12.2.e054219.79","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1016\/j.vaccine.2017.05.001","article-title":"Cost-Effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings","volume":"35","author":"Antill\u00f3n","year":"2017","journal-title":"Vaccine"},{"key":"2025121600182792000_12.2.e054219.80","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy1094"},{"key":"2025121600182792000_12.2.e054219.81","doi-asserted-by":"crossref","first-page":"S222","DOI":"10.1093\/infdis\/jiy543","article-title":"Case-Fatality ratio of blood culture-confirmed typhoid fever in Dhaka, Bangladesh","volume":"218","author":"Yu","year":"2018","journal-title":"J Infect Dis"},{"key":"2025121600182792000_12.2.e054219.82","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1905047"},{"key":"2025121600182792000_12.2.e054219.83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002642"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-054219","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T08:18:42Z","timestamp":1765873122000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-054219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":83,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2,28]]},"published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.1136\/bmjopen-2021-054219"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-054219","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2]]}}}